Two Gene Therapy Players Launch IPOs on Stormy Stock Market
After a drought of more than a year, the European gene therapy sector saw initial…
January 21, 2022 - 4 minutes
IPO
Evotec IPO Hints At Stabilizing Investor Interest In Biotech Stocks
German life sciences heavyweight Evotec raised around €376M ($435M) in its US debut on the…
November 10, 2021 - 4 minutes
Third-Generation DNA Sequencing Shines with Oxford Nanopore’s IPO
Oxford Nanopore Technologies, until recently one of very few unicorns in the European biotech industry,…
October 15, 2021 - 5 minutes
Exscientia IPO Attracts Tech Investor Bets to AI Drug Discovery
Exscientia’s lucrative entry onto the Nasdaq last week demonstrated investors are still excited by efforts…
October 7, 2021 - 5 minutes
Delayed IPOs and Market Drops Batter Biotech Stocks
Stock markets worldwide have experienced painful instability in the last few months. As a result,…
May 25, 2021 - 6 minutes
Pandemic Boosts Diagnostics Field with High Revenues and Acquisitions
The US medtech firm Hologic has bought the Finnish-French biotech Mobidiag for around €668M in…
April 20, 2021 - 5 minutes
Lava Therapeutics’ IPO Shakes Cancer Niche of Gamma Delta T Cells
The Dutch biotech startup Lava Therapeutics launched onto the Nasdaq stock market last week with…
March 31, 2021 - 5 minutes
How to Prepare for a Successful Biotech IPO
Any biotech company that has reached a certain size and is in need of investment…
October 26, 2020 - 10 minutes
Update: ADC Therapeutics’ IPO Hits Above Target with €215M
Update (15/05/2020): The Swiss biotech ADC Therapeutics has priced its IPO on the New York…
May 15, 2020 - 4 minutes
€51M Nasdaq IPO Will Fund Centogene’s Rare Disease Diagnostics
The German company Centogene has raised €50.6M ($56M) in an IPO on the Nasdaq Stock…
November 7, 2019 - 2 minutes
Innate Pharma Raises €62M IPO to Develop Antibody Drugs for Cancer
The French company Innate Pharma has raised a Nasdaq IPO of €62.1M ($68.8M) to fund…
October 17, 2019 - 2 minutes
ADC Therapeutics Cancels Nasdaq IPO Amidst Market Growth Fears
The Swiss biotech ADC Therapeutics has withdrawn its application for a €182M ($200M) Nasdaq IPO,…
October 4, 2019 - 2 minutes
